RT @ASCOPost : Durvalumab Shows Activity in Heavily Pretreated Patients With Non–Small Cell Lung Cancer https://t.co/hWiIRdnFbH #LCSM #oncol…

RT @ASCOPost : Durvalumab Shows Activity in Heavily Pretreated Patients With Non–Small Cell Lung Cancer https://t.co/hWiIRdnFbH #LCSM #oncol…

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/867998420547637249
via IFTTT